Thomas Minarik

Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial

Andreas du Bois, Gunnar B. Kristensen, Isabelle Ray‐Coquard et al. · The Lancet Oncology · 2015 · 207 citations · Full text

Placebo-controlled Phase 3, Medicine, Metronomic Therapy +9

Endocrine disrupting alkylphenolic chemicals and other contaminants in wastewater treatment plant effluents, urban streams, and fish in the Great Lakes and Upper Mississippi River Regions

Larry B. Barber, Jorge E. Loyo-Rosales, Clifford P. Rice et al. · The Science of The Total Environment · 2015 · 125 citations

Endocrine Disruptors, Ecotoxicity, Effluent Disposal +11

Contaminants of emerging concern in tributaries to the Laurentian Great Lakes: I. Patterns of occurrence

Sarah Elliott, Mark E. Brigham, Kathy E. Lee et al. · PLoS ONE · 2017 · 114 citations · Full text

Engineering, Water Contamination, Chemical Pollutant +20

Environmental estrogens in an urban aquatic ecosystem: II. Biological effects

Melissa M. Schultz, Thomas Minarik, Dalma Martinović‐Weigelt et al. · Environment International · 2013 · 51 citations · Full text

Endocrine Disruptors, Estuarine Geochemistry, Water Quality +3

Environmental estrogens in an urban aquatic ecosystem: I. Spatial and temporal occurrence of estrogenic activity in effluent-dominated systems

Dalma Martinović‐Weigelt, Thomas Minarik, Erin M. Curran et al. · Environment International · 2013 · 32 citations · Full text

Estrogenic Activity, Endocrine Disruptors, Aquatic Ecology +6